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. The trend was preserved when increasingly specific definitions of malaria disease were used. The prevalence of malaria infection was not associated with CD4 cell count. In per-visit analysis, lower CD4 cell counts were associated with higher incidences of pneumonia, sepsis, and tuberculosis but not of malaria. Severe malaria was rare, with only 3 cases in 591 person-years of observation. Parasite density and CD4 cell count were independent risk factors for fever.
Conclusions. Profoundly immunosuppressed adults with HIV infection require more-frequent treatment for uncomplicated malaria, but malaria infection and disease are less strongly associated with HIV-associated immunosuppression than are other opportunistic infections. Where malaria is common, the high incidence of fever found among immunosuppressed adults may lead to misclassification of illness episodes as malaria.
HIV infection and Plasmodium falciparum malaria are 2 of the gravest health threats in sub-Saharan Africa. Efforts to control the spread of both of these deadly infections have failed [1, 2] . HIV infection and malaria coexist in large populations in Africa, so even a small interaction between the 2 infections may have important public health consequences. Although the relationship between HIV infection and malaria has been investigated in a variety of settings, no consistent relationship has emerged.
Early studies of the interactions between HIV infection and P. falciparum malaria in infants and young children in Zaire and Uganda found no increased rates of malaria infection in HIV-infected children, compared with those in HIV-uninfected control individuals [3] [4] [5] . In studies in Zambia and Burundi, HIV infection was not found to be associated with cerebral malaria [6, 7] . In 1998, a comprehensive meta-analysis concluded that, among children and nonpregnant adults, there was no evidence of an interaction between HIV infection and malaria [8] .
In a malaria epidemic in South Africa, where transmission of and immunity to malaria are low, HIV infection has been found to be associated with moresevere malaria disease among both adults and children [9, 10] . Increased morbidity due to malaria among HIV-infected pregnant women has been demonstrated in several sites in Africa, and HIV-infected women have a higher incidence of placental malaria [11] . Most of these earlier studies did not measure the degree of immunosuppression.
Two recent studies examined the interaction between malaria and HIV infection among adults in malaria-endemic regions of Uganda, with precise assessment of immunosuppression. Whitworth et al. conducted a longitudinal cohort study of HIVinfected and -uninfected adults in a rural area in Uganda [12] . In that study, increased immunosuppression was found to be associated with increased odds of clinical malaria being detected during routine active surveillance visits, which occurred every 3 months, and a trend toward an increased incidence of clinical malaria was observed during interim passive surveillance visits by participants seeking treatment for illness. In that study, clinical malaria was defined as fever or history of fever accompanied by significant parasitemia, but other potential causes of fever were not reported. Among HIV-infected adults participating in a pneumococcal vaccine trial in Entebbe, Uganda, an increased rate of malarial fever was observed among individuals with lower CD4 cell counts [13] . These study participants were followed every 6 months, and many sought antimalarial treatment outside of the study.
We conducted a longitudinal study of people living with HIV infection in an urban community in Blantyre, Malawi, where malaria is holoendemic with seasonal peaks. We followed the participants monthly and performed a comprehensive investigation into every illness experienced within the cohort. Here, we report our findings regarding the interaction between HIV immunosuppression and malaria.
SUBJECTS AND METHODS

Subjects.
In collaboration with the Malawi National AIDS Control Programme and the District Health Office, we established a Voluntary HIV Counseling and Testing Center at the Blantyre Malaria Project research clinic at the Ndirande Health Centre, on the outskirts of Blantyre, the largest city in Malawi. Free voluntary counseling and testing for HIV was offered as a community service. HIV infection was diagnosed by testing with 2 rapid tests: Determine HIV rapid diagnostic strips (Abbott Laboratories) and UniGold (Trinity Biotech). Hemostrip HIV (Saliva Diagnostics) was used as a third test if the results of the first 2 tests conflicted, in accordance with the Malawi National AIDS Control Programme protocol.
Individuals у16 years of age who were found to be infected with HIV were invited to participate in the study. Inclusion criteria included HIV infection and residence in the study area. The only exclusion criterion was long-term prophylaxis with trimethoprim-sulfamethoxazole (TS), because, at the time of this study, TS prophylaxis was not recommended for people living with HIV infection in Malawi, and the principle objectives of our study were to describe the baseline epidemiology of opportunistic infections and assess the potential role of TS prophylaxis in this setting.
Since this was the first community-based study of people living with HIV infection in Malawi, we had no data on which to base a sample size calculation. Our aim was to recruit 500-800 participants to be followed for 1-2 years to characterize the important infections in the population.
The study protocol was reviewed and approved by the Institutional Review Boards of the University of Maryland and Michigan State University and by the University of Malawi College of Medicine Research and Ethics Committee. Informed consent was obtained from all participants before enrollment in the study. Participants were free to withdraw from the study at any time and continue to receive care at the District Health Center.
Participants who volunteered for the study were evaluated on the day of enrollment and every month thereafter. In addition, participants were instructed to return to the study clinic for evaluation any time they were ill. The clinic was located at the District Health Center serving the area, and the study clinicians under the supervision of physicians provided free, complete, and expeditious care for all illnesses. Diagnostic evaluation of each illness was undertaken in accordance with standardized diagnostic guidelines and case definitions.
Specimen collection. CD4 cell counts were measured at enrollment and every 4 months thereafter (FacsCount; Becton Dickinson). Malaria smears were obtained at enrollment; at every scheduled visit, regardless of symptoms; and at any sick visits when the participant had fever or any other signs or symptoms of malaria disease.
Malaria thick smears were stained with Field's stain, and parasites were counted against 200 white blood cells. Parasite density was calculated on the basis of an estimated white blood cell count of 8000 cells/mm 3 . For smears with high parasite density, thin smears were obtained to measure the percentage of parasitized red blood cells, and parasite density was calculated on the basis of the measured hemoglobin level (HemoCue; HemoCue AB). Extensive evaluation of potential causes of intercurrent fever and illness were conducted as described elsewhere [14] .
Case definitions. Because there is no reference standard method for diagnosis of malaria disease in a malaria-endemic area in which individuals may have asymptomatic infection and symptoms caused by a different illness, increasingly specific definitions were applied to categorize malaria disease. Clinical malaria was a diagnosis made at the time of the clinic visit and refers to any level of parasitemia with symptoms associated with malaria, including fever documented on physical examination or history of fever during the previous 48 h, myalgia, weakness, pallor, and headache. When a clear additional cause of symptomatic disease was found at the same time as parasitemia, the diagnosis of clinical malaria was not made if the parasite density was !1 parasite/high-power microscope field and the study physician determined that the nonmalaria illness could account for all observed symptoms. Clinical malaria with significant parasitemia included cases of clinical malaria that had a parasite density 12790 parasites/mL, the parasite density at which the sensitivity and specificity for fever intersect in this population [15] . Febrile malaria referred to episodes of having a significant level of parasitemia and an axillary temperature у37.5ЊC measured at the time of the visit. All participants with either symptomatic or asymptomatic infection were treated with sulfadoxine-pyrimethamine or with parenteral quinine, for cases of severe disease. Malaria infection, defined as a positive malaria smear, was analyzed in terms of prevalence, because chronic, asymptomatic infection is common, and the time of onset of new malaria infections could not be identified. All case definitions of malaria disease were analyzed as incident events, because disease episodes have identifiable times of onset and resolution.
Data analysis. Data were collected and entered into the database at the Blantyre Malaria Project facility in Ndirande. The database was in Microsoft Access, and double entry was conducted for validation. Data were analyzed using Stata (version 8.0; StataCorp). Months of follow-up were calculated from the date of enrollment until the last recorded visit. Follow-up for participants who missed у2 sequential scheduled visits was censored at the last visit they attended. Rates of disease were calculated on the basis of person-years of observation (pyo). Except where indicated, CD4 cell counts were used from the day of the visit or within the 6 months before the visit, so that individuals contributed events and follow-up time according to this CD4 cell count assignment. World Health Organization (WHO) clinical stage of HIV disease was determined on the basis of the WHO criteria. To determine the clinical stage as accurately as possible, clinical stage classification for analysis was based on the history provided by the participant, as well as on the first 2 months of assessment in the study.
Poisson regression was used to compare malaria incidences by CD4 cell count stratum (!200, 200-500, and у500 cells/ mm 3 ) after age and sex were controlled for. CD4 cell count was used as a continuous variable to measure the association with prevalence of malaria infection. A Poisson goodness-offit test was assessed for overdispersion [16] . When malaria incidences for the 3 CD4 cell count groups are compared, the P value for the comparison between the lowest group and the highest group is reported. Episodes from the enrollment visit were included in the overall incidence but not in the routine or follow-up visit categories. The lack of independence of observations from the same individual was controlled for with the Huber/White/sandwich estimator of variance. x 2 analysis was applied to test the association between CD4 cell count and the diagnosis of pneumonia, sepsis, or tuberculosis; malaria infection prevalence; and clinical malaria with significant parasitemia, reported in number of cases per 1000 visits. Geometric mean parasite density was compared among episodes of parasitemia, using linear regression analysis to assess the relationship between parasite density and CD4 cell count. The association between fever and parasite density, with CD4 cell count controlled for, was assessed by logistic regression. A parasite density-by-CD4 cell count interaction term was considered in the regression model.
RESULTS
Demographics
. Four hundred fifty-seven (66%) of the participants were female. Eighty-six (13%) of the participants died during the study, and 37 (6%) were withdrawn from the study because the investigators placed them on lifelong TS prophylaxis after a suspected case of Pneumocystis jirovecii pneumonia or because they were prescribed TS prophylaxis by a nongovernmental organization that distributed antiretroviral therapy in a neighboring region. Sixty-three (9.5%) of the participants migrated out of the area, 20 (3%) withdrew consent, and 119 (17%) were lost to follow-up.
CD4 cell counts. At enrollment, the mean CD4 cell count was 268 cells/mm 3 Parasitemia and clinical malaria. The rates of clinical malaria with any parasite density, clinical malaria with a significant parasite density, and febrile malaria were 0.35, 0.17, and 0.06 cases/pyo, respectively. Only 3 participants had severe malaria according to the WHO definition [17] , and all 3 had CD4 cell One case was associated with hyperparasitemia (120%), and the other 2 cases were associated with anemia that required transfusion. In one of these cases, the participant had concomitant Salmonella typhimurium bacteremia and died. Table 2 shows the crude malaria incidence and the adjusted rate ratios of malaria disease for each visit type. Increasing incidence of clinical malaria, clinical malaria with significant parasitemia, and febrile malaria were associated with decreasing CD4 cell counts. The difference was not found when routine and sick visits were analyzed separately. CD4 cell count was not associated with prevalence of malaria infection ( ; data not shown). P p .23 CD4 cell count and parasite density. Geometric mean parasite density for all episodes of infection was inversely related to CD4 cell count (regression coefficient, Ϫ.001;
). P p .005 This relationship was restricted to episodes of clinical malaria ( ) and was not seen among participants with asymp-P p .001 tomatic infection ( ). P p .67 Parasite density and fever threshold. To determine whether individuals with lower CD4 cell counts develop symptoms at a lower parasite density, we used a model to determine the probability of fever with increasing parasite density (asexual parasites per cubic millimeter) for the 3 CD4 cell count groups (figure 1). In this model, CD4 cell count and parasite density did not have a statistical interaction in the prediction of fever. As expected, the more-immunosuppressed groups always had a higher incidence of fever. After CD4 cell count was controlled for, the odds of fever increased proportionately with increasing parasite density.
Nonmalarial illnesses. Sepsis, pneumonia, and tuberculosis were more strongly associated with immunosuppression than was malaria. These illnesses are rare in less immunosuppressed adults, whereas all adults in this cohort remained susceptible to clinical malaria (table 3) . Of 325 documented episodes of parasitemia, 22 episodes were associated with additional diagnoses that could have symptoms that overlap with those of malaria and require specific therapy (table 4) .
DISCUSSION
In this urban population of African adults living with HIV infection in a malaria-endemic area, immunosuppression had a modest effect on malaria disease. Consistent with other recent studies of African adults, participants with CD4 cell counts !200 cells/mm 3 had a higher annual incidence of malaria disease than did those with CD4 cell counts 1500 cells/mm 3 . However, unlike recognized opportunistic infections-including bacterial sepsis, pneumonia, and tuberculosis, which were infrequent in relatively more-immunocompetent adults-malaria Table 3 . Frequency per 1000 visits of sepsis, pneumonia, and clinical malaria with significant parasitemia. Clinical malaria with significant parasitemia 6.5 (2.8-12.9) 11.1 (8. (1) a Salmonella typhimurium, ; S. enteriditis,
disease was common in all CD4 cell count strata. Severe disease was rare: there were only 3 cases of severe malaria in 591 pyo; 2 of these cases were categorized as severe malaria on the basis of anemia, which, in adults living with HIV infection, is a common condition that may not be related to malaria. The third case was defined as severe malaria on the basis of a high parasite density only. No cases of cerebral malaria were seen.
Compared with other cohort studies of malaria-HIV infection interactions in African adults [12, 13] , the present study had more-intensive active surveillance, had more-thoroughly investigated nonmalaria causes of fever, and included a higher proportion of persons with low CD4 cell counts. Therefore, the failure to find more-pronounced clinical or parasitological interactions between HIV infection and malaria is unlikely to be due to study design.
The accurate diagnosis of uncomplicated malaria disease in malaria-endemic areas is difficult because of the frequent occurrence of asymptomatic malaria infection. In this study, 3 increasingly specific case definitions were applied. We previously used this approach to document an association between HIV RNA concentration and clinical malaria [18] . In the present study, the consistent association between lower CD4 cell counts and malaria incidence when increasingly rigorous definitions of malaria were used corroborates previous findings of the relationship between HIV-associated immunosuppression and uncomplicated malaria disease. This form of analysis, however, does not eliminate the possibility of detection bias. If more-immunosuppressed individuals had more fevers and were subjected to more medical evaluations that included malaria smears, the incidence of malaria disease episodes may have been falsely elevated. To control for detection bias, we also reported the incidence of malaria disease by visit and found no association with immunosuppression.
Although more-immunosuppressed individuals appear to be somewhat more susceptible to malaria, they are even more vulnerable to other opportunistic infections that may occur coincidentally with malaria infection. Calculating the incidence of disease by visit demonstrates that, even with more-frequent visits by more-immunosuppressed participants, much higher rates of sepsis, pneumonia, and tuberculosis were seen in those with lower CD4 cell counts. In contrast, the inverse relationship between the per-visit incidence of clinical malaria with significant parasitemia and CD4 cell count was not significant. In addition, nearly 1 in 10 episodes of parasitemia among participants with the lowest CD4 cell counts was associated with another clinically important diagnosis. In at least some cases, illness episodes that occur in the presence of malaria infection may be caused not by malaria but by other infections.
We have previously hypothesized that HIV-associated immunosuppression and the lack of acquired immunity to malaria may lower the threshold of parasite density that causes symptoms, particularly fever [19, 20] . Parasite density and CD4 cell count increased the risk of fever independently. Although individuals with lower CD4 cell counts are more likely to have fever-regardless of the presence or density of parasites-as parasite density increased, those who were more immunosuppressed had an increase in the odds of fever, relative to baseline, that was similar to the change from baseline seen in those who were less immunosuppressed.
Most parasite density calculations were derived from thick smears on the basis of an assumed total white blood cell count of 8000 cells/mm 3 . Individual white blood cell counts may have differed substantially from this estimate. Since leukopenia is common in advanced HIV infection [21] , we may have overestimated the parasite density of participants with lower CD4 cell counts.
The results of the present study may not accurately reflect the general experience of patients and clinicians in regions of HIV infection and malaria coexistence. Because of a tendency for people with illness to seek HIV testing and because of the natural decline in CD4 cell count, the study population was skewed toward more-immunosuppressed participants, with only 87 (15%) of 591 pyo of the follow-up time accrued among individuals with a CD4 cell count у500 cells/mm 3 . The participants were followed very closely. Low-level, asymptomatic parasitemia was treated with antimalarial medication, so that we were not able to observe the natural history of asymptomatic infection in our population. Participants had free and expeditious access to medical attention and may have sought medical attention at an earlier stage in their illness than they would have under nonstudy conditions. The intensity of surveillance, however, was applied equally to all participants, regardless of CD4 cell count; thus, any important differences between groups should have been detectable in this study. In addition, as community-based antiretroviral therapy clinics develop in regions of malaria endemicity, closer surveillance and more-frequent therapy for malaria episodes may become more common. The 17% rate of loss to follow-up, although relatively low for a longitudinal cohort study in an urban African population, may have affected the study findings, if those lost to follow-up had significantly different rates of malaria.
Malaria kills people who lack specific, naturally acquired immunity, including infants, young children, and pregnant women in malaria-endemic areas; travelers; and people of all ages in areas without enough malaria transmission to stimulate protective immunity. HIV-associated immunosuppression does not obliterate immunity to malaria. Adults in endemic areas do not return to having the same risk for severe disease and death that they had when they were young. Although uncomplicated P. falciparum malaria will be diagnosed and treated approximately twice as frequently in profoundly immunosuppressed adults living with HIV infection in malaria-endemic areas, these adults do not appear to be at a high risk of progressing to severe disease, even when treated with an antimalarial drug whose efficacy is compromised [22] .
The impact that HIV infection-malaria interactions in African adults has on the diagnosis and treatment of uncomplicated P. falciparum malaria has important public health implications. Where malaria is common, the high incidence of fever found among adults with lower CD4 cell counts may lead to misclassification of illness episodes as malaria disease. The high incidence of fever associated with lower CD4 cell counts makes evaluation and diagnosis of malaria more likely, but this does not imply a causal relationship. Without a means to determine whether malaria parasites are innocent bystanders or the cause of illness, treatment is warranted for anyone with symptoms and a positive malaria smear. However, clinicians who diagnose malaria in HIV-infected adults with fever and parasitemia should take care not to overlook potentially lifethreatening infections with bacteria, fungi, or other parasites.
